药品名称ONCOVIN
申请号014103产品号003
活性成分VINCRISTINE SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格1MG/ML
治疗等效代码参比药物
批准日期1984/03/07申请机构ELI LILLY AND CO
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
014103062AP2001/01/02Control Supplement
014103060AP1999/08/26Labeling Revision
014103059AP1998/04/29Manufacturing Change or Addition
014103058AP1997/10/03Control Supplement
014103055AP1995/11/06Manufacturing Change or Addition
014103053AP1996/03/28Package Change
014103052AP1995/07/05Manufacturing Change or Addition
014103051AP1992/12/16Labeling Revision
014103050AP1992/06/30Labeling Revision
014103049AP1992/04/02Labeling Revision
014103048AP1991/01/02Package Change
014103047AP1991/04/23Control Supplement
014103046AP1990/06/14Labeling Revision
014103044AP1989/06/06Labeling Revision
014103043AP1988/09/16Labeling Revision
014103042AP1988/06/22Package Change
014103040AP1988/04/05Labeling Revision
014103039AP1987/08/17Labeling Revision
014103038AP1987/07/23Control Supplement
014103037AP1987/02/19Manufacturing Change or Addition
014103036AP1986/01/27Labeling Revision
014103035AP1986/03/17Labeling Revision
014103033AP1985/08/16Control Supplement
014103031AP1985/09/23Labeling Revision
014103030AP1984/03/07Labeling Revision
014103029AP1983/09/20Control Supplement
014103027AP1985/05/31Control Supplement
014103026AP1982/05/10Labeling Revision
014103024AP1982/12/09General Efficacy (MarkIV)
014103023AP1981/07/02Control Supplement
014103022AP1981/05/15Labeling Revision
014103021AP1982/04/08Formulation Revision
014103016AP1976/03/12Labeling Revision
014103000AP1963/07/10Approval